Edap Tms (NASDAQ:EDAP) Downgraded by StockNews.com to “Sell”

StockNews.com lowered shares of Edap Tms (NASDAQ:EDAP) from a hold rating to a sell rating in a report published on Friday morning.

Separately, HC Wainwright boosted their price objective on shares of Edap Tms from $16.00 to $19.00 and gave the stock a buy rating in a research report on Monday, April 1st.

Edap Tms Stock Performance

NASDAQ:EDAP opened at $7.26 on Friday. The company has a quick ratio of 2.30, a current ratio of 2.84 and a debt-to-equity ratio of 0.04. Edap Tms has a fifty-two week low of $3.60 and a fifty-two week high of $12.23. The stock has a market cap of $269.38 million, a PE ratio of -11.52 and a beta of 0.74. The firm’s fifty day simple moving average is $7.10 and its 200-day simple moving average is $6.27.

Edap Tms (NASDAQ:EDAP) last posted its quarterly earnings results on Wednesday, March 27th. The medical equipment provider reported ($0.15) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.13). Edap Tms had a negative return on equity of 34.33% and a negative net margin of 35.03%. The company had revenue of $21.27 million for the quarter, compared to analyst estimates of $21.30 million. Analysts expect that Edap Tms will post -0.31 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in EDAP. JPMorgan Chase & Co. purchased a new position in Edap Tms in the 1st quarter valued at about $60,000. HighTower Advisors LLC purchased a new position in Edap Tms in the 1st quarter valued at about $185,000. Envestnet Asset Management Inc. purchased a new position in Edap Tms in the 2nd quarter valued at about $80,000. Jane Street Group LLC purchased a new position in Edap Tms in the 2nd quarter valued at about $86,000. Finally, Royal Bank of Canada lifted its holdings in Edap Tms by 136.4% in the 3rd quarter. Royal Bank of Canada now owns 13,000 shares of the medical equipment provider’s stock valued at $107,000 after purchasing an additional 7,500 shares in the last quarter. 62.74% of the stock is currently owned by hedge funds and other institutional investors.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.